Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Citi
Harvard Business School
Novartis
Healthtrust
Boehringer Ingelheim
Chinese Patent Office
Medtronic
McKesson

Generated: October 18, 2017

DrugPatentWatch Database Preview

Norfloxacin - Generic Drug Details

« Back to Dashboard

What are the generic sources for norfloxacin and what is the scope of norfloxacin patent protection?

Norfloxacin
is the generic ingredient in two branded drugs marketed by Merck and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for norfloxacin.

Summary for Generic Name: norfloxacin

US Patents:0
Tradenames:2
Applicants:1
NDAs:2
Drug Master File Entries: see list7
Bulk Api Vendors: see list74
Clinical Trials: see list17
Patent Applications: see list6,086
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:norfloxacin at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
NOROXIN
norfloxacin
TABLET;ORAL019384-002Oct 31, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
CHIBROXIN
norfloxacin
SOLUTION/DROPS;OPHTHALMIC019757-001Jun 17, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: norfloxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
CHIBROXIN
norfloxacin
SOLUTION/DROPS;OPHTHALMIC019757-001Jun 17, 1991► Subscribe► Subscribe
Merck
NOROXIN
norfloxacin
TABLET;ORAL019384-002Oct 31, 1986► Subscribe► Subscribe
Merck
NOROXIN
norfloxacin
TABLET;ORAL019384-002Oct 31, 1986► Subscribe► Subscribe
Merck
CHIBROXIN
norfloxacin
SOLUTION/DROPS;OPHTHALMIC019757-001Jun 17, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
QuintilesIMS
Novartis
Accenture
Express Scripts
Merck
Teva
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot